EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Dose Acetaminophen as a Treatment for Cancer

Jeffrey Wu, Bradley Maller, Rujul Kaul iD, Andrea Galabow, Allyn Bryan, Alexander Neuwelt

Livers · 31.01.2024 · 4 (1) · 84-93

DOI: 10.3390/livers4010007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Livers, online erschienen am 31.01.2024. Verfasst von Jeffrey Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, Oregon Health and Sciences University, 3181 Sam Jackson Park Rd., Portland, OR 97239, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of high-dose acetaminophen (AAP) with n-acetylcysteine (NAC) rescue was studied as an anti-cancer treatment in phase I trials with promising signals of anti-tumor efficacy. Correlative analysis suggested that AAP has a free-radical-independent mechanism of anti-tumor activity—in contrast to the well-established mechanism of AAP hepatotoxicity. Subsequent “reverse translational” studies in the pre-clinical setting have identified novel mechanisms of action of high-dose AAP, including modulation of JAK-STAT signaling in both the tumor cell and the tumor immune microenvironment. Importantly, these effects are free-radical-independent and not reversed by concurrent administration of the established AAP rescue agents fomepizole and NAC. By administering high-dose AAP concurrently with fomepizole and NAC, 100-fold higher AAP levels than those of standard dosing can be achieved in mice without detected toxicity and with substantial anti-tumor efficacy against commonly used mouse models of lung and breast cancer that are resistant to standard first-line anti-cancer therapies. With these recent advances, additional clinical trials of high-dose AAP with concurrent NAC and fomepizole-based rescue are warranted.

Schlagwörter

Stichwörter der Autor:innen

N-acetylcysteineacetaminophencancerfomepizole

Autor:innen und Institutionen

  • Department of Neurology, School of Medicine, Oregon Health and Sciences University, 3181 Sam Jackson Park Rd., Portland, OR 97239, USA.
  • Department of Veterans Affairs, 1201 Broad Rock Blvd, Richmond, VA 23249, USA.
  • Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, 1201 E Marshall St., Richmond, VA 23298, USA.

ORCID-Profile: Rujul Kaul

Förderung

  • BLRD VA
  • Department of Veterans Affairs

Zitieren

APA

Wu, J., Maller, B., Kaul, R., Galabow, A., Bryan, A., & Neuwelt, A. (2024). High-Dose Acetaminophen as a Treatment for Cancer. Livers, 4(1), 84-93. https://doi.org/10.3390/livers4010007

Vancouver

Wu J, Maller B, Kaul R, Galabow A, Bryan A, Neuwelt A. High-Dose Acetaminophen as a Treatment for Cancer. Livers. 2024;4(1):84-93. doi:10.3390/livers4010007

BibTeX
@article{Wu2024,
  author = {Wu, Jeffrey and Maller, Bradley and Kaul, Rujul and Galabow, Andrea and Bryan, Allyn and Neuwelt, Alexander},
  title = {High-Dose Acetaminophen as a Treatment for Cancer},
  journal = {Livers},
  year = {2024},
  volume = {4},
  number = {1},
  pages = {84--93},
  doi = {10.3390/livers4010007}
}
Kostenlos starten →